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Abstract: During the last decade, due to advances in functionalization chemistry, novel 
nanobiomaterials with applications in tissue engineering and regenerative medicine have been 
developed. These novel materials with their unique physical and chemical properties are bioactive 
hierarchical structures that hold great promise for future development of human tissues. Thus, 
various nanomaterials are currently being intensively explored in the directed differentiation 
of stem cells, the design of novel bioactive scaffolds, and new research avenues towards tissue 
regeneration. This paper illustrates the latest achievements in the applications of nanotechnology 
in tissue engineering in the field of regenerative medicine.
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Introduction
Tissue engineering and regenerative medicine have been constantly developing of 
late due to the major progress in cell and organ transplantation, as well as advances in 
materials science and engineering. Isolated from a variety of embryonic, fetal, and adult 
tissues, stem cell populations have the advantage of being significantly proliferative and, 
therefore, could be extremely efficient in the treatment of presently incurable diseases 
in the near future. Moreover, their unique characteristics related to the differentiation, 
regeneration, development, remodeling, and replenishment of aged and diseased tissues 
make them perfect candidates in this area. In a very easy and simple way, stem cells can 
be conceptually divided into two types: embryonic stem cells (ESCs) – derived from 
a very early embryo and adult stem cells – found in postnatal tissues, of both the body 
(bone marrow [BM], adipose tissue, etc) and the umbilical cord (UC).1
Their high self-renewal capacity and pluripotency in differentiating into deriva-
tives of all germ layers in vitro and in vivo have made embryonic stem cells leading 
candidates for tissue engineering research and regenerative medicine, covering a 
wide range of therapeutic areas, including the treatment of several neurological and 
cardiac disorders, diabetes, hematopoietic diseases, liver diseases, and lung diseases. 
However, in addition to ethical and political concerns, their clinical application is 
severely limited by their lack of accessibility and the difficulties that impede purifica-
tion and manipulation techniques, as well as concerns related to the risk of teratoma 
formation.2
On the other hand, mesenchymal stem cells, one of the many types of adult 
stem cells, also have a high self-renewal capability and expansive potential ex 
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vivo. Furthermore, they are more versatile in changing 
their phenotype during differentiation, are present in large 
numbers in adults, and are also relatively easy to isolate 
and culture, features which make them suitable for tissue 
regeneration and cell-based therapy.3 Because mesenchymal 
stem cells of multiple adult vertebrate species originate from 
extra embryonic mesoderm, their capacity to differentiate 
into adipogenic, chondrogenic, and osteogenic lineages as 
well as into myogenic and fibroblastic lineages has been 
extensively studied.2,4 Further, controversial data indicate 
that mesenchymal stem cells may give rise to sarcomeric 
muscle (skeletal and cardiac) cells, endothelial cells, and 
even cells of non-mesodermal origin, such as hepatocytes, 
neural cells, and epithelial cells.5 However, in contrast, Yang 
et al6 concluded that the mechanism underlying the promot-
ing effect on the regeneration of several corticospinal axons 
and locomotor recovery after spinal cord transection in the 
rat following human umbilical cord mesenchymal stem cell 
transplantation is likely via the release of more cytokines 
or growth factors from undifferentiated stem cells rather 
than the differentiation of these cells into neuronal or glial 
cells. In support of this, Rossignol et al also suggested that 
recovery of motor function in a 3-nitropropionic acid rat 
model of Huntington’s disease was likely due to release of 
trophic factors from bone marrow mesenchymal stem cells 
because very few transplanted mesenchymal stem cells 
demonstrated evidence of transdifferentiation.7 Moreover, 
in spite of the fact that some researchers have successfully 
transformed Wharton’s jelly-derived human umbilical cord 
blood mesenchymal stem cells into cardiomyocytes using 
5-azacytidine or cardiomyocyte-conditioned medium and 
noted slight spontaneous beating,2 others have failed to 
generate cardiomyocyte-like cells from human umbilical 
cord blood mesenchymal stem cells, either spontaneously 
or after use of various protocols, including addition of 
chemicals (5-azacytidine and dimethyl sulfoxide), growth 
factors, Wnt signaling activators, and direct contact with 
neonatal rat cardiomyocytes.8,9 Though mesenchymal stem 
cells have been demonstrated to differentiate in culture into 
several distinct mesenchymal lineages and possibly into 
other cell types, including astrocytes, oligodendrocytes, 
neuronal cells, cardiomyocytes, pancreatic β-cells, and 
hepatocytes,4,10 poor engraftment and limited differentia-
tion under in vivo conditions are drawbacks that limit their 
therapeutic efficiency.11 Consequently, better monitoring 
and evaluation tools for engineered tissues, and especially 
for new biomaterials, are needed to facilitate tissue growth 
and stem cell differentiation.
Nanomaterials have unique advantages in controlling 
stem cell function and in tissue regeneration (Figure 1) due 
to their biomimetic characteristics and special biological 
and mechanical properties.12 Researchers have focused 
on application of nanomaterials in the biomedical field 
because of the fact that provision of an appropriate nano-
biointerface can secure the control of cellular behavior, 
and, therefore, optimal tissue regeneration.13–16 Moreover, 
research activity in this field has been fuelled by recent 
advances in nanomaterial preparation, increasing aware-
ness on the part of materials science and tissue engineering 
researchers regarding the potential role of stem cells in 
regenerative medicine, and advances in stem cell biology. 
Most of the research has focused on development of novel 
nanoparticles or nanotubes for stem cell imaging17 and for 
potential delivery of chemotherapeutic agents to tumors, 
respectively.18 However, these nanoparticles have several 
other potential applications, ie, as intracellular drug car-
riers to control stem cell differentiation and as biosensors 
to monitor intracellular levels of relevant biomolecules/
enzymes in real time. The nanoparticles most commonly 
used in stem cell research are organic and inorganic nano-
particles,19,20 liposomes,21 polyplexes,22 quantum dots,23 and 
carbon nanotubes.24,25 In addition, some synthetic materials, 
such as polylactide-co-glycolide (PLGA), poly-caprolac-
tone, and natural materials, such as collagen and   chitosan, 
can be used as nanoparticles in medical   applications. 
The following are some potential applications of these 
nanoparticles in stem cell research: non-invasive tracking of 
stem cells and progenitor cells transplanted in vivo; intra-
cellular delivery of DNA, RNA interference molecules, 
proteins, peptides, genes,26 and small drugs for stem cell dif-
ferentiation or survival, and biosensing of the physiological 
state of stem cells.25 Therefore, osteogenic or chondrogenic 
differentiation of stem cells has been obtained by intracel-
lular delivery of growth factors mediated by nanoparticles.27 
Stem cells were also transfected using nanoparticles encap-
sulated with plasmid DNA encoding bone morphogenetic 
protein (BMP)2, which induce ondotogenic or osteogenic 
differentiation.28,29
Nanomaterials for controlling 
differentiation of stem cells
Tissue regeneration is tightly related to the process of 
controlling adhesion and differentiation of stem cells. The 
ability to deliver biomolecules, including proteins, growth 
factors, and small chemicals, via an intracellular route 
presents an excellent tool to control the differentiation 
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of stem cells. Some of these biomolecules/chemicals 
have poor solubility, can be quickly cleaved by cellular 
enzymes, and have various side effects when administered 
systemically.
Biodegradable and biocompatible nanoparticles which 
have the ability to target stem cells and release their pay-
load in the cytoplasm, followed by activation of signaling 
cascades, are likely to be the focus of future research. For 
example, Ferreira et al have already reported a new approach 
for the delivery of vascular growth factors in human 
embryonic stem cells, in which growth factor-releasing 
particles are incorporated in human embryoid bodies.20 They 
showed that incorporation of these polymeric biodegradable 
particles had a minimal effect on cell viability and prolifera-
tion, but had a large impact on differentiation. The effect 
on vascular differentiation of particles containing growth 
factors was, in some cases, even higher than that observed by 
exposing embryoid bodies to large extrinsic doses of the same 
growth factors. This unique feature enables nanoparticles 
to be used as a platform to deliver growth factors and other 
biomolecules within stem cells.25 In response to the strong 
demand for development of stem cell differentiation, carbon 
nanotubes have emerged as a promising material for tissue 
engineering, due to their tremendous strength, ultralight 
weight, and high stability, as well as their ability to become 
very ﬂexible after suitable functionalization.30,31
Hepatocyte differentiation
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Figure 1 Stem cell differentiation mediated by bionanomaterials with applications in regenerative medicine.
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Differentiation into mesenchymal-
osteogenic, adipogenic, chondrogenic 
lineage
Mesenchymal stem cells
Bone regeneration
In the geriatric field, osteoporosis, osteoarthritis, periodontitis, 
and other skeletal diseases are the major targets of   regenerative 
medicine. As the average age of the population rises, the inci-
dence of these diseases also continues to rise, and although 
they are not usually life-threatening, they often severely affect 
the quality of life of elderly patients.   Moreover, vertebral 
compression fractures, the most common fragility fractures, 
account for approximately 700,000 injuries per year. Given 
that open surgery involves a considerable risk of morbidity 
and implant failure in the osteoporotic patient population, a 
new minimally invasive biological solution to vertebral bone 
repair is needed.32 Although substantial progress in regenera-
tive medicine, bone scaffolds, and cartilage tissue engineer-
ing has been made in the past few years, it still falls short of 
clinical requirements.
Specific bioactive growth factors, nutrients, and environ-
mental cues can direct human mesenchymal stem cell dif-
ferentiation into mesodermal lineages, including osteoblasts, 
chondrocytes, and adipocytes.33 In vivo studies have shown 
that bone repair processes in adults resemble normal devel-
opment of the skeleton during embryogenesis. Recent data 
suggest that osteoclasts and mesenchymal stem cells are the 
main cells involved in bone formation, whereas parathyroid 
hormone-related protein, Wnt, mitogen-activated protein 
kinases, and BMPs, including BMP2 and BMP7, represent 
crucial signaling proteins in these processes34 and can induce 
osteoblast-like genes and matrix mineralization in primary 
human mesenchymal stem cell culture.12,35 Bone and cartilage 
tissue engineering is emerging as a promising therapeutic 
tool that aims both to repair damaged tissues and to regener-
ate them fully by combining cells, biomaterials mimicking 
extracellular matrix (scaffolds), and regulatory signals.36
The mechanical profile of bone is the most important 
factor to consider when designing a material to be used as 
a bone scaffold.37 Consequently, because of their excellent 
mechanical strength, carbon nanotubes and carbon nanofibers 
have been the focus of many studies related to the use of these 
nanostructures as reinforcing agents in composite materials38,39 
and especially in bone scaffolds.40–42   Additionally, single-
walled carbon nanotubes (SWCNTs) are less dense than other 
metallic or ceramic-based bone scaffolds used in orthopedics 
(eg, titanium, stainless steel, alumina), so will produce lighter 
scaffolds with very high strength.
Pristine SWCNTs do not have any inherent properties in 
order to support new bone growth. As previously mentioned, 
carbon nanotubes/carbon nanofibers can be functionalized 
with different side groups which can improve the biocom-
patibility properties43 and/or mechanical strength44 in tube-
based/fiber-based scaffolds.42 Therefore, conjugating carbon 
nanotubes with functional groups that attract calcium cations 
enables carbon nanotubes to be used as scaffolds for bone 
regeneration.43 For example, SWCNTs were functionalized 
with poly(aminobenzene sulfonic acid) (PABS) using amida-
tion of the carboxylic acid groups on SWCNTs (CNT-COOH) 
with amines (PABS) through an acyl chloride intermediate 
(CNT-COCl): SWCNT-COOH → SWCNT-COCl → 
SWCNT-PABS.43 Thin films of either SWCNT-COOH or 
SWCNT functionalized with PABS (SWCNT-PABS) were 
deposited on glass slides and soaked for 7 days in a solution of 
CaCl2 and Na2HPO4. At the end of this period, a large amount 
of “plate-shaped hydroxyapatite crystals” could be identified 
throughout the whole surface of the thin SWCNT-PABS 
films. Additionally, researchers found that the thickness of 
the hydroxyapatite layer was 2.4 µm, growing to a thickness 
of 3.5 µm after 14 days, whereas thin SWCNT-COOH films 
showed no increase in mineralization between 7 and 14 days. 
The experiment thus offered a method of producing carbon 
nanotubes which support hydroxyapatite mineralization by 
functionalizing the tubes with negatively charged groups 
(ie, PABS).42
PLGA, a copolymer of polylactic acid and polyglycolic 
acid, is a biodegradable polyester. Its variable molecular 
weight and composition enables it to be rationally designed 
to control the release kinetics of encapsulated therapeutic 
agents. The incorporation of osteoconductive nanohydroxy-
apatite into PLGA can improve the mechanical and biologi-
cal properties of the scaffold and moderate the degradation 
rate.45,46 Furthermore, nanohydroxyapatite-PLGA scaffolds 
proved to be associated with higher rabbit mesenchymal 
stem cell growth and alkaline phosphatase activity than 
PLGA scaffolds.47 In a very recent study, Lock and Liu 
investigated the effects of nanohydroxyapatite, PLGA, and 
nanohydroxyapatite-PLGA composites on the functions 
of bone marrow-derived human mesenchymal stem cells 
in comparison with a short functional peptide of BMP7. 
For peptide DIF-7c loading, nanohydroxyapatite was 
functionalized by aminosilane chemistry (HA-Ps), whereas 
for the peptide-loaded nanocomposites (HA-Ps-PLGA), 
HA-Ps was dispersed in PLGA, as described elsewhere.12 
To fabricate the PLGA scaffold with the peptide (PLGA-P) 
as a control, the peptide DIF-7c was dispersed directly in 
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the PLGA matrix using the solvent casting method. Human 
mesenchymal stem cells from Lonza were cultured up to the 
second passage and seeded at a density of 5000 cells/cm2 
in mesenchymal stem cell growth medium into 12-well 
culture plates with the scaffolds and controls. The cells 
were cultured in mesenchymal stem cell growth medium 
for the first 6 days and, thereafter, in osteogenic induction 
media to induce osteogenesis. Osteogenic differentiation of 
human mesenchymal stem cells was studied in the nanocom-
posites and control scaffolds (HA-Ps-PLGA, HA-PLGA, 
PLGA-P, PLGA), on nanohydroxyapatite (with and without 
the DIF-7c peptide), on glass and PSTC references, as 
well as with direct injection of the DIF-7c peptide into the 
cell culture medium. Alkaline phosphatase is an enzyme, 
the production of which is associated with increased 
osteogenic differentiation of human mesenchymal stem 
cells, whereas calcium deposition represents the ultimate 
indicator of human mesenchymal stem cell differentiation. 
Both alkaline phosphatase activity and calcium deposition 
determinations after 40 days in culture demonstrated that 
nanophase hydroxyapatite and HA-PLGA nanocomposites 
can induce osteogenic differentiation of human mesenchy-
mal stem cells, similar to the DIF-7c peptide. Moreover, 
DIF-7c peptide functionalization to nanohydroxyapatite and 
in nanocomposites did not show any significant effect in 
promoting adhesion or osteogenic differentiation of human 
mesenchymal stem cells when compared with nanohydroxy-
apatite and nanocomposites without the peptide. There was 
no detectable calcium deposition in the PLGA-P and PLGA 
scaffolds. However, when both the nanohydroxyapatite and 
the DIF-7c peptide were present in human mesenchymal 
stem cells culture, the enhancing effects of nanohydroxy-
apatite on osteogenic differentiation of human mesenchymal 
stem cells were more clearly pronounced than that of the 
DIF-7c peptide (Figure 2). These results support the use 
of HA-PLGA composites in promoting new bone growth 
without using expensive BMPs or BMP-derived peptides. 
However, their effects on human mesenchymal stem cell 
and bone tissue regeneration still need to be further studied 
in vivo for clinical translation.12
Their good bioinert and mechanical properties48,49 have 
promoted titanium and its alloys as some of the most widely 
used implants in the clinical setting. TiO2 nanotube layers were 
previously fabricated with controlled diameters by anodizing 
titanium in adequate electrolytes.37,50 Several studies dem-
onstrated that TiO2 nanotubes of different diameters could 
affect the proliferation and differentiation of mesenchymal 
stem cells.37,51 For example, Park et al demonstrated that the 
nanoscale TiO2 surface topography significantly inﬂuences 
the vitality, proliferation, and motility of mesenchymal stem 
cells, as well as their differentiation into bone-forming cells, 
a specific response being noted for nanotubes with diam-
eters between 15 and 100 nm.51 For instance, the adhesion, 
proliferation, migration, and differentiation in mesenchymal 
stem cells were maximally induced on 15 nm nanotubes, 
but prevented on 100 nm nanotubes, which induced cell 
death (Table 1). Moreover, the response of freshly isolated 
hematopoietic stem cells from human umbilical cord blood 
with respect to differentiation into multinucleated osteoclasts 
showed the same size-dependent response to TiO2 nanotubes; 
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Figure 2 Osteogenic differentiation of human mesenchymal stem cells characterized by calcium deposition. The human mesenchymal stem cells were cultured with the 
materials as listed in the column.
Notes: Data are presented as the mean ± standard error of the mean (n = 3). *P , 0.05 compared with glass and PSTC (8 and 9); **P , 0.05 compared with PLGA-P and 
PLGA (5 and 6); #P , 0.05 compared with DIF-7c peptide (7). Reprinted with permission Yang et al.6
Abbreviations: MSC, mesenchymal stem cells; HA, hydroxyapatite; PLGA, polylactide-co-glycolide; P, peptide; Ps, peptide loaded by aminosilane chemistry; HA-Ps, nano-HA 
loaded with peptide using aminosilane chemistry; PLGA-P, PLGA scaffold loaded with peptide; PTSC, polystyrene tissue culture plate; DIF-7c, peptide-derived short peptide. 
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differentiation to multinucleated and tartrate-resistant 
acid phosphatase-positive osteoclasts was significantly 
stimulated on nanotubes below 30 nm compared with 
smooth TiO2 surfaces. Similar to mesenchymal stem cells, 
cell proliferation of human osteoblast-like cells, as well as 
mineralization of human osteoblast-like cells and expression 
of osteogenic marker proteins, such as osteocalcin, were 
again highest on 15 nm nanotubes (Table 1), as compared 
with larger size nanotubes or smooth surfaces. However, 
what was interesting was that coculture with osteoclasts on 
15 nm nanotubes did not impede osteogenic differentiation 
including mineralization, but the latter was not stimulated in 
coculture on 100 nm nanotubes. These results clearly indicate 
that the nanoscale microenvironment strongly controls bone 
cell differentiation by the interaction between osteoblasts and 
osteoclasts via cell-cell contacts and soluble factors from each 
cell type during coculture in vitro. The clustering of integrins 
into focal adhesion complexes and activation of intracellular 
signaling cascades into the nucleus and into the cytoskeleton 
mediate cell interactions with extracellular surfaces.52 It can 
be hypothesized that a spacing of 15–30 nm may result from 
the compact clustering of integrin receptor molecules with the 
actual size of the extracellular domain being about 10 nm, into 
focal contacts by the 15 nm spacing of the nanotubes. This 
would explain the focal contact formation, cell proliferation, 
migration, and differentiation occurring at a higher rate on 
15 nm nanotubes than on polished TiO2 or non-nanoporous 
surfaces.37,51,53
In another experiment, long-term osteoblast function 
was compared on fabricated carbon fiber compacts that were 
Table 1 Summary of the literature reports indicating applications of some nanomaterials in stem cell differentiation and proliferation
Study Stem cell  
population
Nanomaterial used Tissue cell type  
generated
Park et al37 HUCB-HSCs 15 nm TiO2 nanotubes Osteoclasts
Park et al37 HOBs 15 nm TiO2 nanotubes Osteoblasts
Elias et al54 Osteoblasts Nanometer diameter CNFs Enhances functions of 
osteoblasts
Nayak et al31 HMSCs MwCNT-PEG (in the absence  
of any additional growth factor)
Osteoblasts
Lai et al50 Rat BM-MSCs BMP2-functionalized 30 nm  
(PDOP)-TiO2 nanotubes
Osteoblasts
Lock and Liu12 HBM-MSCs Nano-HA-PLGA composites;  
nano-HA-Ps-PLGA; nano-HA-Ps
Osteogenic differentiation
Li et al70 Myoblastic mouse  
cells (C2C12)
MwCNT compacts Osteoblasts
Namgung et al65 HBM-MSCs Aligned CNT networks (without  
osteogenic supplements) versus  
randomly oriented CNT networks
Enhances proliferation and  
osteogenic differentiation  
on aligned CNT networks
Jan and Kotov71 Mouse embryonic  
neural stem cells
LBL-assembled SwNT-polyelectrolyte  
composite
Neurons, astrocytes, 
oligodendrocytes
Sridharan et al72 HESCs Type 1 collagen/SwCNT composite  
material
Neural progenitor cells
Kam et al73 Neural stem cells SWCNT/laminin thin-film composite Neurons, glial cells
Chao et al74 HESCs PAA-g-CNTs 2D thin films Neurons
Chao et al75 HESCs PMAA-g-CNTs thin-film scaffolds Neurons
Tay et al84 HMSCs Carboxylated SWNT films Neurons
Andersen et al69 HMSCs siRNA NP functionalization of  
nanostructured scaffolds
Osteogenic, adipogenic  
differentiation: bone and fat cells
Spadaccio et al77 HMSCs PLLA/HA nanocomposite Chondrocyte-like cells
Tsukahara and  
Haniu78
Myoblastic mouse  
cells (C2C12)
Highly purified multiwall carbon  
nanotube (HTT2800)
Adipose-like lineage
Lee et al76 Mouse embryonic  
fibroblasts
Cationic polymer PEI-coated super  
paramagnetic NP conjugated with plasmid  
DNAs containing each of the iPS factor gene
Exogenous DNA-free safe  
iPS cell lines
Ghaedi et al85 HBM-MSCs PLLA/collagen nanofiber scaffold Hepatocyte-like cells
Abbreviations: HUCB-HSCs, human umbilical cord blood hematopoietic stem cells; HOBs, human osteoblast-like cells; HMSCs, human mesenchymal stem cells; MwCNTs, 
multiwalled carbon nanotubes; PEG, poly(ethylene glycol); BM-MSCs, bone marrow mesenchymal stem cells; HESCs, human embryonic stem cells; BMP2, bone morphogenetic 
protein 2; PDOP, polydopamine; HA, hydroxyapatite; nano-HA-PLGA, nano-HA-polylactide-co-glycolide; Ps-PLGA, polylactide-co-glycolide with peptide; SwCNTs, single-
walled carbon nanotubes; PAA-g-CNTs, PAA-poly(acrylic acid) grafted carbon nanotubes; PMAA-g-CNTs, PMAA-polymethacrylic acid grafted carbon nanotubes; SiRNA, 
small interfering RNA; iPS cells, induced pluripotent stem cell; PLLA/HA, PLLA-poly-L-lactic acid/hydroxyapatite; LBL, layer by layer.
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either nanophase (ie, dimensions #100 nm) or conventional 
(ie, dimensions .100 nm).54 The authors showed that osteo-
blasts synthesized more alkaline phosphatase and deposited 
more extracellular calcium on the nanophase compacts than 
on the conventional compacts. It has been surprisingly noted 
among nanophase compacts that the higher the calcium content 
in the extracellular matrix, the lower the carbon fiber   diameter. 
These results clearly show that osteoblast functions are 
  significantly increased by carbon nanofibers, which were not 
functionalized with bioactive molecules, but, on the contrary, 
demonstrated novel properties in their raw state.42
Carbon nanotubes, with their unique physical and 
chemical properties are emerging as versatile tools in nano-
medicine.31,55–57 It is widely known that the extracellular 
matrix can exert highly complex biochemical effects in a 
manner similar to that of growth factors (eg, BMP2),58 result-
ing in dramatic changes to cell phenotypes. In this context, 
Nayak et al conducted a study to research whether and how 
polyethylene glycol (PEG)-conjugated multiwalled carbon 
nanotubes (MWCNTs) can, as a composite biomaterial, 
promote osteogenic differentiation of human mesenchymal 
stem cells and simultaneous bone matrix mineralization in 
the absence of any biochemical inducer. Interestingly, both 
BMP2-treated substrates and MWCNT-PEG-coated (without 
BMP2) coverslips showed comparable cell differentiation 
into bone cells. Though no growth factors were added, 
MWCNT-PEG managed to transform human mesenchymal 
stem cells into bone-like cells successfully (Table 1). This 
has been demonstrated by multiple independent criteria at the 
transcript (eg, OPN), protein (eg, osteocalcin), and functional 
(eg, calcium deposition) levels showing that exposing mes-
enchymal stem cells to an appropriately selected biomaterial 
may induce cell differentiation into a targeted tissue type like 
osteoblasts. On the contrary, cells on the MWCNT-COOH 
substrates showed slightly irregular shapes, suggesting 
poor adherence to the substrate and thus lower cell growth 
(cell viability about 75%).31 This is in agreement with an 
experiment by Liu et al59 in which carboxylated SWCNTs 
and MWCNTs inhibited cell proliferation and osteogenic dif-
ferentiation of human mesenchymal stem cells, consequently 
demonstrating the potential cytotoxicity of carboxylated 
carbon nanotubes.
BMP2 has been demonstrated to promote osteogenesis 
when incorporated into hyaluronic acid hydrogels along with 
mesenchymal stem cells.60 Recently, Lai et al successfully 
fabricated surface-functionalized TiO2 nanotubes with BMP2 
through the intermediate layer of polydopamine, which fur-
ther promoted the osteogenic differentiation of mesenchymal 
stem cells (Table 1). Mesenchymal stem cells grown on 
BMP2-functionalized TiO2 nanotubes displayed higher 
expression of vinculin, an intracellular protein involved in 
linkage among cell adhesion membranous molecules, integ-
rins, and actin filaments, and higher cell viabilities after 7 and 
14 days of culture than those grown on native TiO2 nanotubes. 
Moreover, cell proliferation was affected not only by grafted 
BMP2 but also by the nanoscale surface topography. Thus, 
the growth tendency was higher for mesenchymal stem cells 
grown on native TiO2 nanotubes with diameters of 30 nm 
and 60 nm than that for mesenchymal stem cells grown on a 
titanium substrate and 100 nm TiO2 nanotubes. Furthermore, 
the highest mineralization and highest alkaline phosphatase 
activity for all the groups were identified in mesenchymal 
stem cells cultured on BMP2-polydopamine 30 nm TiO2 
nanotubes. The approach described here can be applied in 
the development of titanium-based implants for enhanced 
bone osseointegration.50
While several studies have showed that differentiation 
of human mesenchymal stem cells is controlled simply by 
modulating the disorder or the dimension of nanostructures 
and the degree of differentiation in those cases was similar 
to that in the cases where soluble cues were used,61 it seems 
that the arrangement of individual carbon nanotubes, such 
as aligned carbon nanotube networks, is also critical to 
control the growth direction as well as differentiation of 
mesenchymal stem cells.62–64 The ability of human mesen-
chymal stem cells to identify individual carbon nanotubes 
in carbon nanotube networks and the fact that the growth 
and differentiation of these cells is affected by alignment of 
individual carbon nanotubes can account for the observed 
enhanced proliferation and osteogenic differentiation of 
human mesenchymal stem cells on aligned carbon nanotube 
networks compared with those on randomly oriented carbon 
nanotube networks. The upregulation of genes involved in 
the mechanotransduction pathways in human mesenchymal 
stem cells on aligned carbon nanotube networks supports 
the hypothesis that mechanotransduction pathways produced 
by the high cytoskeletal tension in elongated human mes-
enchymal stem cells on aligned carbon nanotube networks 
enhanced proliferation and osteogenic differentiation.65
In another in vitro study, Price et al tested the adhesion 
of osteoblasts, fibroblasts, chondrocytes, and smooth muscle 
cells on polycarbonate urethane/carbon nanofiber composite 
scaffolds. They found that composites with smaller-scale 
(ie, nanometer dimension) carbon fibers promoted osteo-
blast adhesion but did not promote adhesion of other cells. 
Surprisingly, smooth muscle cell, fibroblast, and chondrocyte 
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adhesion decreased when the carbon nanofiber surface energy 
increased, suggesting that greater weight percentages of 
high surface energy carbon nanofibers in the polycarbonate 
urethane/carbon nanofiber composite increased osteoblast 
adhesion while, at the same time decreasing fibroblast 
  adhesion. This can only prove that surface energy has a big 
inﬂuence on cell adhesion and subsequent cell functions.66
Small interfering RNAs (siRNAs) can silence synthesis 
of a specific protein by base pairing with its mRNA sequence 
when introduced into cells67 and, therefore, be very likely 
candidates in the genetic treatment of cancer, as demon-
strated also by Wu et al, who used PEG-polyethyleneimine 
(PEI) as a non-viral carrier of siRNA targeting CD44v6 in 
gastric carcinoma cells.68 The first example of an siRNA 
  nanoparticle-functionalized scaffold able to regulate stem 
cell differentiation was developed by Andersen et al.69 
  Adipogenesis and osteogenesis are two oppositely regulated 
pathways, and differentiation enhancers are known to down-
regulate genes relating to the opposite pathway.   Consequently, 
these researchers showed that specific targeting of TRIB2 and 
Bcl2-L2 on implants in vitro and in vivo leads to enhanced 
adipogenic and osteogenic differentiation from human 
mesenchymal stem cells, respectively, in specific locations 
within the same implant by placing different siRNA in distinct 
locations. Moreover, it appears that siBCL2L2 and siTRIB2 
can initiate early osteogenic and adipogenic differentiation, 
respectively, as demonstrated by in vivo findings (Figure 3). 
However, they cannot induce terminal differentiation as the 
sole differentiation cue. Importantly, the nanostructured 
nature of the scaffolds enables nanoparticle retention and 
localization of different siRNAs to distinct parts of an 
implant. This made it possible to guide stem cells into alter-
nate differentiation in specified locations. Therefore, this 
method is very likely to become an efficient and realistic 
strategy to engineer tissues and organs that contain multiple 
cell types.69
Chondrogenic differentiation
Because mature articular cartilage cannot heal spontaneously 
due to its low mitotic activity, the search for a cell type 
capable of both repopulating tissue loss and reconstituting 
the connective environment crucial for cartilage function is 
required. The role of hydroxyapatite and tricalcium phosphate 
in facilitating and promoting cartilage regeneration79,80 
and biomineralization in cartilage has been demonstrated. 
Scaffolds, the pivotal structure of engineered tissue, set 
the environment for neoextracellular matrix synthesis. The 
scaffold component is expected to lead the process of tissue 
development by supporting cell colonization, migration, 
growth, and differentiation. The process of electrospin-
ning the poly-L-lactic acid (PLLA)/hydroxyapatite system, 
obtained by dispersing nanopowders of hydroxyapatite in a 
PLLA solution, was employed to fabricate hybrid PLLA-
hydroxyapatite membranes. Consequently, Spadaccio 
et al tested the putative chondrogenic differentiation of 
human mesenchymal stem cells following culture on a 
hydroxyapatite-functionalized scaffold. After 14 days of 
culture, cells positive for the chondrogenic transcription 
factor, SOX-9, could be detected in the PLLA-hydroxyapatite 
nanocomposite in a significantly greater percentage than in 
the PLLA scaffold. Although limited by the lack of quantita-
tive data on mRNA expression of chondrogenic markers to 
be able to speculate on the actual degree of   differentiation 
obtained, the experiment managed to demonstrate that elec-
trospun PLLA-hydroxyapatite nanocomposites can induce 
differentiation of human mesenchymal stem cells into 
chondrocyte-like cells that produce a proteoglycan-based 
matrix77 (Table 1).
Other cell lines
Adipose-like cell differentiation
Myoblastic mouse cells (C2C12) are a well established and 
commonly used in vitro model for the study of myogenic 
differentiation.81 They have been shown to have pluripotent 
mesenchymal precursor cell characteristics. Tsukahara et al78 
tested the ability of one of the most highly purified MWCNTs 
(HTT2800) to modulate the proliferation and differentiation 
of the skeletal muscle cell line, C2C12. The major finding of 
this study was that HTT2800 greatly inﬂuenced intracellular 
lipid accumulation in C2C12 cells. Moreover, quantified 
polymerase chain reaction analysis showed that expression 
of adipose-related genes was markedly upregulated during 
HTT2800 exposure (Table 1), whereas expression of muscle-
specific genes (myogenin, MyoD) was reduced. Overall, 
these findings demonstrate, for the first time, that HTT2800 
promotes the transition from a myogenic lineage to an adipose-
like lineage, partly determined by CD36 overexpression.78
Osteogenic differentiation
In myoblastic mouse cell C2C12 cultures, cell attachment, 
proliferation, and differentiation was shown to be better on 
MWCNT compacts than on graphite compacts. Moreover, the 
alkaline phosphatase activity in C2C12 cells on MWCNTs 
was also significantly higher than on graphite, and this sup-
ports the idea that MWCNTs are responsible for inducing 
C2C12 cell differentiation into osteogenic cells to a greater 
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extent than graphite and that MWCNTs can be considered 
to be an osteoproductive material.70
Differentiation into non-mesenchymal 
neural cell and hepatocyte-like lineages
Valuable insight into the way in which carbon nanotubes 
inﬂuence neuronal cell differentiation can be crucial in 
developing new applications, such as improved cell culture 
substrates, neural probe coatings, and nerve guidance 
conduits.65 The central nervous system has a very poor 
regenerative potential and is difficult to access. This partly 
explains why neurological diseases including stroke and 
neurodegenerative disorders such as Parkinson’s disease, 
Alzheimer’s disease, and Huntington’s disease which typi-
cally result from irrevocable damage and improper func-
tioning of specialized neuronal cells often lack appropriate 
therapies. Neural disease is currently among the complicated 
and significant clinical problems in the world, with around 
250,000–400,000 people being reported to live with a spinal 
cord injury and 13,000 additional people suffering spinal 
cord injuries each year in the United States. More and more 
neural implants will be needed as the population increases 
and ages. However, compared with other tissues (such 
as bone tissue), operations of repairing damaged nerves 
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Figure 3 In vitro and in vivo double differentiation of human mesenchymal stem cells (EGFP negative) seeded on scaffolds where one side was coated with TransIT-
TKO nanoparticles containing TRIB2-targeted siRNA (#1) and the other side with TransIT-TKO nanoparticles containing BCL2L2-targeted siRNA (#1). (A) In vitro double 
differentiation. The dual-coated scaffolds were seeded with human mesenchymal stem cells and cultured for 2 days in maintenance medium and 8 days in complex medium. 
The sides were then separated and for each side the ratios of the mRNA levels of PPARγ2, RUNX2, AP2, ADN, OC and alkaline phosphatase relative to the mRNA level 
of B2M were determined. The ratios of the marker expression between the side with the TRIB2-targeted siRNA (#1) and the side with the BCL2L2-targeted siRNA (#1) 
were characterized and plotted. Averages are graphed with error bars representing standard deviation (n = 3 or 4). The y-axis is logarithmic and the markers that were 
upregulated on the side coated with TRIB2-targeted siRNA compared with the side coated with BCL2L2-targeted siRNA will have values above 1 and vice versa. (B–D) In vivo 
differentiation on a dual-coated scaffold. The dual-coated scaffolds were seeded with human mesenchymal stem cells for 16 hours in maintenance medium. They were then 
implanted subcutaneously in non-obese diabetic/severe combined immunodeficient mice for 2 weeks, after which they were surgically removed and studied by histology. 
whole scaffold sections were stained with (B) hematoxylin and eosin, (C) Sirius red, and (D) von Kossa. Mosaic pictures of whole scaffold sections at × 10 magnification are 
displayed with the BCL2L2 siRNA-coated side in the top of the pictures, host tissue can be seen surrounding the implant. On the Sirius red-stained section, collagen deposition 
appears red and birefringence appears orange. Images in (B) and (C) are 7.6 mm wide and 8.4 mm high, and (D) is 7.6 mm wide and 6.5 mm high. Reprinted with permission 
from Andersen et al.69
Abbreviations: ADN, adiponectin; ALP, alkaline phosphatase; AP2, apolipoprotein 2; B2M, β-2 microglobulin; COL1, collagen type I; EGFP, enhanced green fluorescent 
protein; LPL, lipoprotein lipase; OC, osteocalcin; PPARγ2, peroxisome proliferator-activated receptor-γ isoform 2; siRNA, small-interfering RNA. 
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and their full recovery are hampered by the complexity of 
nervous system anatomy and function.42 Over the last decade, 
the potential for therapeutic use of stem cell transplantation 
for cell replacement or as cellular vectors for gene delivery 
in neurometabolic and neurodegenerative diseases has 
received a great deal of interest. The interaction between 
stem cells and extracellular microenvironment plays an 
important role in controlling stem cell differentiation via 
chemical, electrical, and physical signals. The diameter and 
length of carbon nanotubes has been shown to be similar to 
those of extracellular matrix molecules, such as collagens 
and laminins, known to enhance neuron growth. Therefore, 
carbon nanotubes have also been extensively studied for 
biomedical applications due to their excellent mechanical 
strength, ﬂexibility, and conductivity.74,75 Carbon nanotubes 
are able to maintain the structural integrity of the scaffolds 
during cell growth and differentiation and have demonstrated 
effects similar to other various biomaterial substrates which 
promote neural differentiation of stem cells.82 On the other 
hand, the ability of stem cells to differentiate into various 
cell types, including neurons, makes them an important ele-
ment for regenerative medicine to be used in the treatment 
of various neurological disorders.42
Mesenchymal stem cells
Depending on the local microenvironment, mesenchymal 
stem cells have the ability to differentiate into several 
specific cell lineages.83 Tay et al examined how carboxylated 
SWCNT films inﬂuenced the behavior of mesenchymal stem 
cells in the absence of a specific differentiation   medium.84 
  Mesenchymal stem cells spread and proliferated on SWCNT 
films, and neurogenic markers were upregulated, while osteo-
genic markers remained low. Distribution of focal adhesion 
was more homogenous in cells grown on the SWCNT surface, 
compared with controls grown on glass. The conclusion of 
this study was that mesenchymal stem cell differentiation 
seems to be inﬂuenced by the nanotopography provided by 
carbon nanotubes.82
Furthermore, very recently, a nanofibrous scaffold 
composed of PLLA and collagen, fabricated by the electro-
spinning technique, proved to be a matrix conducive to the 
differentiation of human bone marrow-derived mesenchymal 
stem cells into functional hepatocyte-like cells. Importantly, 
the expression levels of liver-specific markers, such as 
albumin, α-fetoprotein, and cytokeratins 8 and 18, and the 
secretion of liver functioning serum proteins, albumin and 
α-1 antitrypsin, into the culture medium were higher in 
differentiated cells on the nanofibers than when they were 
cultured on plates, demonstrating that the nanofibrous scaf-
folds promoted and enhanced human bone marrow mesen-
chymal stem cell differentiation into a hepatocyte lineage85 
(Table 1). Although the results of the experiment conducted 
by Ghaedi et al must be confirmed by future researchers, 
their observations might represent the first step for the use 
of this nanofibrous scaffold for culture and differentiation 
of stem cells that may be used in tissue engineering and for 
the treatment of liver failure.
Neural stem cells
Neural stem cells have the ability to differentiate into neu-
rons and glial cells. Hence, mouse embryonic neural stem 
cells from the cortex were successfully differentiated into 
neurons, astrocytes as well as oligodeendrocytes on layer-
by-layer assembled SWNT-polyelectrolyte multilayer thin 
films. Biocompatibility, neurite outgrowth, and expression 
of neural markers were similar to those differentiated on 
poly-L-ornithine, a standard substratum commonly used for 
neuron culture.71 However, differences could be noted after 
a 7-day period of culture because the composites selectively 
promoted more neurons and fewer astrocytes than the com-
mon poly-L-ornithine substrate used for neural studies. 
The results proved that PEI-functionalized SWCNTs were 
cytocompatible for stem cell growth and that they play an 
important role in differentiating stem cells into neuronal 
cells42 (Table 1).
In a study conducted by Kam et al on the inﬂuence of 
SWCNTs on the effects of laminin films on neural stem 
cell cultures,73 laminin-SWCNT films proved to support the 
growth and proliferation of neural stem cells and trigger 
longer outgrowths as compared with pure laminin sub-
strates. Moreover, the study also showed that layer-by-layer 
films consisting of SWCNTs and laminin can serve as a 
biocompatible substrate for promoting adhesion and dif-
ferentiation as well as for mediating electrical stimulation 
of neuronal cell lines. Neural stem cells precursors could 
still be identified 7 days post-seeding on the heat-treated 
SWCNT-laminin substrate (Figure 4). However, protein 
marker expression (microtubule-associated protein 2, glial 
fibrillary acidic protein) showed the presence of large 
amounts of differentiated neurons and glial cells, due to 
spontaneous differentiation likely caused by the physical 
properties of the SWCNT-laminin composites. These results 
are a proof of the fact that thin composite SWCNT-laminin 
films can be employed as materials in the foundation of 
neural electrodes with a chemical structure better adapted to 
long-term integration with neural tissue.
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Figure 4 Micrograph assessing NSC cell adhesion and differentiation 72 hours after initial seeding on (A) laminin-coated glass slides and on 10 bilayered thin SwCNT-laminin 
films that were (B) used as is or (C) heated at 300°C for 10 minutes. (D) Distance of outgrowth from neurospheres after 24 hours (yellow), 48 hours (red), 72 hours (blue), 
and 120 hours (green) on laminin-coated slides and heat-treated SWCNT-laminin film on slide. (E) Live-dead viability assay on seeded cells where live cells are stained green 
and dead cells are red. 
Note: Scale bars are 200 µm. Reprinted with permission Kam NwS, Jan E, Kotov NA. Electrical stimulation of neural stem cells mediated by humanized carbon nanotube 
composite made with extracellular matrix protein. Nano Lett. 2008;9(1):273–278. Copyright 2008 American Chemical Society. 
Abbreviations: NSC, neural stem cells; SwCNTs, single-walled carbon nanotubes. 
Human embryonic stem cells
Human embryonic stem cells are able to differentiate into 
almost all cell types according to regulated spatial and tem-
poral signals. Therefore, human embryonic stem cells possess 
the potential to provide a nearly unlimited supply of cell types 
and are extremely promising for regenerative medicine and 
cell-based transplantation therapy in many neurological and 
neurodegenerative diseases.86
Sridharan et al72 explored the use of a composite collagen-
carbon nanotube material as an in vitro cell culture matrix to 
direct the early differentiation of human embryonic stem cells 
to neural progenitor cells. It is known that type I collagen, 
as an extracellular matrix protein, intensifies the growth of 
many neuronal cell types87 as well as the neural differentiation 
of human embryonic stem cells in a neural differentiation 
medium.88 Carboxyl-modified SWCNTs were used to obtain 
a composite material with type I collagen, the stiffness and 
structure of which proved to be greatly inﬂuenced by carbon 
nanotubes (Figure 5). This resulted in the early differentiation 
of more than 90% of the cells into nestin-positive cells, likely 
to be neural progenitor cells (Table 1). Additionally, ectoder-
mal cell-specific long filaments also resulted from the process 
of culturing embryonic stem cells on collagen-SWCNT gels. 
The physical changes induced by adding SWCNTs to the col-
lagen film account for the increased degree of differentiation 
and provide insight into how carbon nanotubes can impact 
the behavior of progenitor and stem cells.89
Polyacrylic acid (PAA) is a weak acid and has a negative 
effect on neuron differentiation and neuronal cell attachment.90 
However, the same PAA grafted onto carbon nanotubes has 
been demonstrated to have a strong ability to differentiate 
human embryonic stem cells into   neurons. Therefore, the 
branches identified on the differentiated neurons in the new 
two-dimensional thin film composed of PAA grafted onto 
carbon nanotubes are more numerous, and this indicates 
that these differentiated neurons were more mature than 
those on pure PAA control surfaces, which produced lower 
levels of neural differentiation. Furthermore, this new type of 
thin-film scaffold enhances embryonic stem cell growth and 
increases cell adhesion in comparison with conventional poly-
L-ornithine surfaces, as well as pure PAA control surfaces. 
Surface analysis and cell adhesion studies have demonstrated 
the role played by carbon nanotube-based scaffolds in increas-
ing protein adsorption and cell attachment. This makes carbon 
nanotube-based materials into excellent candidates for human 
embryonic stem cells’ neuron differentiation.74
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The same group performed a follow-up study on the 
ability of PAA-grafted MWCNTs, pure MWCNTs, as well 
as MWCNTs functionalized with polymethacrylic acid 
(PMAA)75 to promote differentiation of human embry-
onic stem cells into neuronal cells, using poly-L-ornithine 
as a reference. The results of the study strongly sustain the 
ability of carbon nanotube-based nanofibrillar surfaces, hav-
ing enhanced cell adhesion and growth factor adsorption 
similar to the extracellular matrix, to boost stem cell dif-
ferentiation. The highest nitrogen content was identified for 
the surfaces coated with PMAA-functionalized MWCNTs. 
There are two cues that account for the strong affinity to 
proteins: a physical topographical cue, ie, the combination 
of large surface area and nanoscale grooves given by carbon 
nanotubes, and a chemical one, respectively, the less acidic 
and more hydrophobic environment provided by PMAA 
functionalization. PMAA-coated surfaces demonstrated 
better embryoid body adhesion and higher yield of neuronal 
cells differentiated from embryoid bodies when PMAA was 
compared with PAA, proving, thus, the significant role played 
by surface chemistry in cell adhesion. The highest density of 
neuronal cells has been generated by surfaces coated with 
PMAA-grafted carbon nanotubes, the value of which was 
even higher than that of poly-L-ornithine. This is in agree-
ment with recent reports demonstrating that the adhesion of 
neuronal cells is regulated by roughened surface.91 Therefore, 
it can be concluded that human embryonic stem cells can 
directly provide relatively mature neuronal cells when these 
new polymer-grafted carbon nanotube thin-film scaffolds 
are used, because they assure the appropriate microenviron-
ment, with physical and chemical cues that enable direct 
attachment and differentiation of human embryonic stem cell   
colonies.75
Other applications of nanomaterials  
in stem cell differentiation
Induced pluripotent stem cells
Modern regenerative medicine has been targeting the gen-
eration of patient-specific induced pluripotent stem (iPS) 
cell lines,92 but has been facing the technological problem of 
using potentially harmful genome-integrating viral DNAs, 
which might lead to oncogenesis. Moreover, several recent 
high profile publications have demonstrated that iPSC lines 
can retain both genetic and epigenetic “memories” of the 
differentiated cell from which they were derived.93 Hence, 
a number of challenges need to be addressed in order to 
effectively use these cell lines for disease modeling and for 
stem cell   transplantation. Such challenges include the low 
efficiency of iPS cell generation without genetic alterations, 
the possibility of tumor formation in vivo, the random inte-
gration of retroviral-based delivery vectors into the genome, 
and the unregulated growth of the remaining cells that are 
partially reprogrammed and refractory to differentiation.94 The 
great interest in generating human iPS cells without perma-
nent genetic alterations has prompted a group of researchers 
to publish a schematic representation of the various causes 
and possible safeguards regarding human iPSC genomic 
  instability.95 Very recently, Lee et al76 generated iPS cells using 
a non-viral magnetic nanoparticle-based transfection method. 
Biodegradable cationic polymer PEI-coated super paramag-
netic nanoparticles were complexed to plasmid DNAs which 
comprised each of the four iPS factor genes. The complex was 
exposed to the magnetic forces that guide gene vectors for 
all nucleic acid transfection toward normal mouse embryonic 
fibroblasts. Results of dynamic light scattering analysis and 
transmission electron microscopic analyses showed efficient 
conjugation of nanoparticles with iPS genes. Transfection 
Figure 5 Atomic force microscopy characterization (amplitude images) of the surface structures of gelatin (A), collagen (B), and collagen/carbon nanotubes (C) matrices 
prepared under the cell culture conditions. 
Note: Image size, 8.5 × 8.5 µm2, inset 2 × 2 µm2.  Reprinted with permission from Sridharan et al.89
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was followed by nanofection-mediated iPS cells exhibiting 
embryonic stem cell-like characteristics, such as expression 
of endogenous pluripotency genes, differentiation of three 
germ layer lineages (endoderm, mesoderm, ectoderm) and 
formation of teratomas. Of particular interest, more than 60% 
of the iPS cells produced were not integrated with exogenous 
plasmid DNAs. The conclusion of their study was that non-
viral magnet-based nanofection of iPS genes resulted in three-
fold higher efficiencies of exogenous DNA-free safe iPS cell 
line production, compared with results from other groups that 
exhibit behavior patterns similar to those of embryonic stem 
cells in various aspects.76
Conclusion
Although research in medicine and technology has reached 
peaks seemingly unattainable before, there still are incur-
able diseases that not only hamper quality of life but can 
also lead to death. Engineering of tissues and organs that 
contain multiple cell types (eg, pancreas) might become an 
efficient and realistic strategy for the treatment of incurable 
diseases in the near future. Tissue engineering, imaging, and 
drug delivery is a promising field that has been developing 
intensely due to the rapid progress in nanotechnology as well 
as in stem cell research. Scaffold functionalization tuned 
to each specific application and cell response is a recent 
trend in tissue engineering. Improving the cellular response, 
creating an appropriate nanobiointerface, and the loading and 
delivery of drugs or bioactive molecules as well as enhanc-
ing the bioactivity of the scaffolds can lead to optimization 
of nanofibrous materials for transplantation and clinical 
application. However, further research is needed to elucidate 
the biological impact of nanoparticles on stem cells.
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